Glycosidases catalyze carbohydrate breakdown via multiple mechanisms, implying chemical biology advances in drug discovery.
Glycoside hydrolases, “glycosidases”, catalyze carbohydrate catabolism, remodeling, and signaling by accelerating glycosidic-bond cleavage by more than 17 orders of magnitude. Distributed across every kingdom of life and grouped into over 180 sequence-defined families, these enzymes exhibit exceptional diversity in fold, mechanism, and physiological function, and many also catalyze transglycosylation or phosphorolysis. The classical Koshland paradigms─stereochemical inversion, enzymatic nucleophile-assisted retention, and substrate-assisted retention─are analyzed with an emphasis on the conformational itineraries and oxocarbenium ion-like transition states revealed by kinetic isotope effects, linear free-energy relationships, and high-resolution three-dimensional structures. Attention then turns to noncanonical enzymes that employ NAD + -dependent redox hydrolysis or other cleavage mechanisms. Mechanistic insights have inspired the development of engineered glycosidase-derived catalysts for programmed bond construction as well as mechanism-based inhibitors, transition-state analogues, and activity-based probes that are driving advances in chemical biology, biotechnology, and drug discovery.
No takes yet. Share an insight, caveat, or question.
Overkleeft et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: